EnsiliTech: Funding, Investors & Team (Oct 2026)
To stop degradation, which can result in vaccine spoilage, our cutting-edge ensilication method takes use of the development of protective silica nanoshells on the surface of vaccine components. Once implemented, our vaccines can be delivered and stored without the use of a cold chain, reducing waste, extending shelf life, and enhancing vaccination accessibility globally. Ensilication can be used to shield a wide range of biomolecules from environmental deterioration, doing away with the need for cold chains and encouraging the development of additional oral and mucosal delivery systems for both human and animal vaccines and medicines. We are currently seeking collaborators to help us develop innovative technologies outside of the cold chain.
EnsiliTech has raised $1.1M across 1 funding round on record, the most recent a Pre-Seed of $1.1M announced in Jan 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
EnsiliTech Company Profile and Key Stats
Latest funding round on record: Jan 2023.
EnsiliTech Funding Rounds
EnsiliTech Founders and Leadership Team
Contact details for the EnsiliTech team: 1 of 1 has an email address on file.
Start 14-day free trial →EnsiliTech Funding Compared to Other Biotechnology Startups
EnsiliTech's latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like EnsiliTech in Biotechnology and Bath
Companies Similar to EnsiliTech
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
EnsiliTech Funding FAQs
What does EnsiliTech do?
To stop degradation, which can result in vaccine spoilage, our cutting-edge ensilication method takes use of the development of protective silica nanoshells on the surface of vaccine components. Once implemented, our vaccines can be delivered and stored without the use of a cold chain, reducing waste, extending shelf life, and enhancing vaccination accessibility globally. Ensilication can be used to shield a wide range of biomolecules from environmental deterioration, doing away with the need for cold chains and encouraging the development of additional oral and mucosal delivery systems for both human and animal vaccines and medicines. We are currently seeking collaborators to help us develop innovative technologies outside of the cold chain.
How much funding has EnsiliTech raised?
EnsiliTech has raised $1.1M across 1 round on record. The most recent is a Pre-Seed of $1.1M announced in Jan 2023.
When did EnsiliTech last raise funding?
EnsiliTech's most recent funding round on record is a Pre-Seed of $1.1M, announced in Jan 2023.
Who is the CEO of EnsiliTech?
Asel Sartbaeva is listed as CEO at EnsiliTech.
Where is EnsiliTech headquartered?
EnsiliTech is based in Bath, Bath And North East Somerset, United Kingdom.
How many employees does EnsiliTech have?
EnsiliTech is in the 1-10 employee band.
How does EnsiliTech's funding compare to other Biotechnology startups?
EnsiliTech's latest round of $1.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's EnsiliTech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for EnsiliTech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.